CPT code 57513 denotes surgical laser ablation of cervical tissue, a targeted treatment used to remove or destroy abnormal cervical epithelium. The code is clinically significant nationwide because it captures a specific minimally invasive cervical procedure that can be used for management of precancerous lesions, symptomatic lesions, or other cervical pathology identified by a clinician. Accurate coding affects clinical records, procedural tracking, and payer adjudication across commercial and public plans.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the procedural definition and clinical context, plus expected places of service. The publication also outlines the types of benchmarks and policy elements typically relevant to this code, such as payer coverage considerations, reimbursement benchmarks, and coding compliance issues when performing laser ablation of the cervix.

This summary is intended for a national audience of billing professionals, clinicians, and policy analysts seeking a clear, standalone reference for CPT code 57513. The content highlights what the code represents, where the service is usually provided, and the topics a reader can expect in the full publication, including benchmarking, payer policy snapshots, and clinical context. Data not available in the input will be noted in the detailed sections as necessary.